Satellite Symposia Programme

*as of September 30, 2013 – subject to change

Friday, December 13, 2013
12:00-13:30

Lunch Satellite Symposium – MSD 

 

Current and Future Strategies for the Managment of Osteoporosis: Signaling a Change in the Conversation

 

Welcome

 

Pharmacologic Management of Osteoporosis: Risk Benefit Analysis

 

Alendronate plus Vitamin D3 versus Calcitriol for the Treatment of Osteoporosis in China

 

Cathepsin K Inhibition: A Novel Approach to the Treatment of Osteoporosis

 

Q & A and Closing

 

Saturday, December 14, 2013

12:00–13:00

Lunch Satellite Symposium – GlaxoSmithKline

 

Vital Dimensions in Management of Postmenopausal Osteoporosis
Chairs: Dr. Tai-Pang Ip (HKG)

 

Welcome and Introduction  
Tai-Pang Ip (HKG)

 

The Role of Cortical and Trabercular Deterioriation in Bone Fragility of Postmenopausal Osteoporosis
Ego Seeman (AUS)

 

Sustainability of Anti-Fracture Efficacy and Safety of Denosumab in Postmenopausal Osteoporosis
David Kendler (CAN)       

 

Q & A, Summary and Closing